About Cassiopea
Cassiopea is a company based in Lainate (Italy) founded in 2009 was acquired by Cosmo Pharmaceuticals in October 2021.. The company has 653 employees as of April 06, 2024. Cassiopea operates in a competitive market with competitors including Revance Therapeutics, Dermavant, Sol-Gel Technologies, SkinMedica and Hugel, among others.
- Headquarter Lainate, Italy
- Employees 653 as on 06 Apr, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Jurisdiction Shaikpet, Telangana, India
-
Annual Revenue
$41.42 M (USD)59.42as on Mar 31, 2023
-
Net Profit
$6.79 M (USD)281.61as on Mar 31, 2023
-
EBITDA
$10.42 M (USD)246.16as on Mar 31, 2023
-
Latest Funding Round
- Investors
-
Employee Count
653
as on Apr 06, 2024
-
Acquired by
Cosmo Pharmaceuticals
(Oct 04, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cassiopea
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cassiopea
Cassiopea has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Cosmo Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapeutics for gastrointestinal diseases are developed and provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cassiopea
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cassiopea
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cassiopea Comparisons
Competitors of Cassiopea
Cassiopea operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Revance Therapeutics, Dermavant, Sol-Gel Technologies, SkinMedica and Hugel, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developing topical drug products for the treatment of rosacea, acne and interdigital tinea pedis.
|
|
| domain | founded_year | HQ Location |
Skin care products are developed and manufactured by SkinMedica.
|
|
| domain | founded_year | HQ Location |
Therapeutics in aesthetics are developed, including botulinum toxin products.
|
|
| domain | founded_year | HQ Location |
Solutions for dermatological therapeutics and consumer products are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cassiopea
Frequently Asked Questions about Cassiopea
When was Cassiopea founded?
Cassiopea was founded in 2009.
Where is Cassiopea located?
Cassiopea is headquartered in Lainate, Italy. It is registered at Lainate, Lombardy, Italy.
How many employees does Cassiopea have?
As of Apr 06, 2024, the latest employee count at Cassiopea is 653.
What is the annual revenue of Cassiopea?
Annual revenue of Cassiopea is $41.42M as on Mar 31, 2023.
What does Cassiopea do?
Cassiopea, founded in 2009 and based in Lainate, Italy, operates as a clinical-stage pharmaceutical company specializing in dermatology. Topical treatments for acne, androgenic alopecia, and genital warts are targeted through four drug candidates: Winlevi in Phase III for acne, Breezula in Phase II for alopecia, another for acne in Phase II, and one for HPV in Phase I. The company was renamed from Cosmo Dermatos in April 2015.
Who are the top competitors of Cassiopea?
Cassiopea's top competitors include Revance Therapeutics, Dermavant and Collplant.
Who are Cassiopea's investors?
Cassiopea has 1 investor. Key investors include Cosmo Pharmaceuticals.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.